These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2096427)

  • 21. [Visceral kala-azar of Spanish origin. Apropos of a case].
    De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
    Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
    [No Abstract]   [Full Text] [Related]  

  • 22. Severe leucopenia during treatment of visceral leishmaniasis.
    Hiçsönmez G; Jama H; Ozsoylu S
    Trans R Soc Trop Med Hyg; 1988; 82(3):417. PubMed ID: 3232176
    [No Abstract]   [Full Text] [Related]  

  • 23. Visceral leishmaniasis and renal tuberculosis in a patient on maintenance haemodialysis.
    Peces R; de la Torre M; Alcázar R
    Nephrol Dial Transplant; 1996 Apr; 11(4):707-8. PubMed ID: 8671866
    [No Abstract]   [Full Text] [Related]  

  • 24. Kala azar with disseminated dermal leishmaniasis.
    Kumar PV; Sadeghi E; Torabi S
    Am J Trop Med Hyg; 1989 Feb; 40(2):150-3. PubMed ID: 2919725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the treatment of visceral leishmaniasis.
    Davidson RN; Croft SL
    Trans R Soc Trop Med Hyg; 1993; 87(2):130-1, 141. PubMed ID: 8393221
    [No Abstract]   [Full Text] [Related]  

  • 26. Visceral Leishmaniasis in Renal Transplant Recipients: Report of 2 Cases.
    Clavijo Sánchez F; Vázquez Sánchez T; Cabello Díaz M; Sola Moyano VE; Jironada Gallego C; Hernández Marrero D
    Transplant Proc; 2018 Mar; 50(2):581-582. PubMed ID: 29579858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of kala-azar in India.
    Thakur CP
    Natl Med J India; 1992; 5(5):203-5. PubMed ID: 1338871
    [No Abstract]   [Full Text] [Related]  

  • 29. [Visceral leishmaniasis in infants without bioptic demonstration of the parasite. Presentation of 3 cases].
    Cataldo F; Violante M; Bellia L; Traverso MG; Albeggiani A
    Pediatr Med Chir; 1989; 11(1):81-4. PubMed ID: 2717490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Our experiences in visceral leishmaniasis therapy.
    Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
    J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
    [No Abstract]   [Full Text] [Related]  

  • 31. Chemotherapy of experimental visceral leishmaniasis in the opossum.
    White MR; Chapman WL; Hanson WL
    J Parasitol; 1989 Feb; 75(1):176-8. PubMed ID: 2918440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B].
    Kilani B; Amari L; Belhaj S; Goubontini A; Ben Chaabene T
    Tunis Med; 2004 Mar; 82(3):316-9. PubMed ID: 15382468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Visceral leishmaniasis: a study of 15 cases].
    Laguna F; Gazapo E; Martínez P; Enriquez A; Puente S; García Aguado C; González Lahoz JM
    An Med Interna; 1992 Apr; 9(4):161-4. PubMed ID: 1581449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancytopenia in a simultaneous pancreas and kidney transplant recipient: an unexpected cause - a case of visceral leishmaniasis in a transplant recipient.
    Aardema H; Sijpkens YW; Visser LG
    Clin Nephrol; 2009 Apr; 71(4):460-2. PubMed ID: 19356384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
    Garcia-Cordoba F; Ortuño FJ; Segovia M; Gonzalez Diaz G
    Ann Trop Med Parasitol; 2005 Mar; 99(2):125-30. PubMed ID: 15814031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
    Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
    Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visceral leishmaniasis and disseminated intravascular coagulation in a dog.
    Font A; Gines C; Closa JM; Mascort J
    J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].
    Bouguila J; Chabchoub I; Moncef Y; Mlika A; Saghrouni F; Boughamoura L; Essoussi AS
    Arch Pediatr; 2010 Nov; 17(11):1566-70. PubMed ID: 20880678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of visceral leishmaniasis in Somalia: achievements in a challenging scenario, 2013–2015.
    Wkly Epidemiol Rec; 2017 Sep; 92(35):566-72. PubMed ID: 28945058
    [No Abstract]   [Full Text] [Related]  

  • 40. [Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
    Magnan A; Jacquème P; Sudan N; Redding E; Blanc AP; Poirier R
    Rev Pneumol Clin; 1991; 47(4):188-91. PubMed ID: 1723216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.